AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases (Leah Rosenbaum/Forbes)


Leah Rosenbaum / Forbes:

AI-based drug discovery company Recursion raises $239M Series D and partners with pharma giant Bayer to develop new treatments for fibrotic diseases — Startups that want to leverage artificial intelligence in drug discovery are a dime a dozen in today’s biotech landscape.




Source link

Click Here to Leave a Comment Below 0 comments

Leave a Reply: